Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trialMichael Weller, Maciej M. Mrugała, Nicholas Butowski et al.|The Lancet Oncology|2017Cited by 1.1k
Glucarpidase for treatment of high-dose methotrexate toxicityShruti Gupta, Anthony Nicolaysen, Jason Prosek et al.|Blood|2025Cited by 30
CLIN-IMMUNOTHERAPY/BIOLOGIC THERAPIESIan F. Pollack, Frank S. Lieberman, Regina I. Jakacki et al.|Neuro-Oncology|2012Cited by 1